Amor Gamoudi
Overview
Explore the profile of Amor Gamoudi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oueslati M, Sassi N, Bettaieb I, Gamoudi A, Rahal K, Oueslati R
Tunis Med
. 2023 Sep;
101(2):273-279.
PMID: 37682272
Introduction: Tumor Growth Factor-β (TGF-β) is a multifunctional cytokine that plays a crucial role in various biological processes. TGF-β is also involved in various pathologies including breast cancer (BC). BC...
2.
Oueslati M, Bettaieb I, Ben Younes R, Gamoudi A, Rahal K, Oueslati R
J Clin Med Res
. 2022 Nov;
14(10):416-424.
PMID: 36406947
Background: Signal transducers and activators of transcription 5a and 6 (STAT5a and STAT6) play a critical role in tumorigenesis of mammary glands. Based on previous studies, the breast cancer is...
3.
Zawati I, Adouni O, Manai M, Nagara M, Tacam M, Reduzzi C, et al.
Hum Immunol
. 2022 Sep;
83(12):843-856.
PMID: 36068099
Classical Hodgkin lymphoma (CHL) is characterized by extensive inflammatory immune cells, which predict the disease prognosis. Therefore, this study aimed to explore the significance of different tumor-infiltrated immune cells and...
4.
Manai M, Abdeljaoued S, Goucha A, Adouni O, Bettaieb I, Bouzaien H, et al.
Cancer Biomark
. 2019 Nov;
26(4):513-522.
PMID: 31771045
Background: Male breast cancer (MBC) is a rare and aggressive disease. Thus, identification of new therapeutic targets is crucial. Objective: Our objective was to evaluate the protein expression of MARCKS...
5.
Manai M, Finetti P, Mejri N, Athimni S, Birnbaum D, Bertucci F, et al.
Mol Clin Oncol
. 2019 Jan;
10(2):223-230.
PMID: 30680198
To report epidemiological and anatomo-clinical features within a retrospective series of inflammatory breast cancer and to evaluate prognostic factors. This retrospective study included 210 Tunisian patients presenting a clinically diagnosed...
6.
Benna M, Slimane M, Smaoui W, Syrjanen K, Belaid A, Bouaziz H, et al.
Tunis Med
. 2018 Nov;
96(4):183-258.
PMID: 30430521
No abstract available.
7.
Amine O, Belghith M, Salhi H, Goucha A, Gamoudi A
Avicenna J Med
. 2018 Apr;
8(2):55-57.
PMID: 29682479
Lipoblastoma is a rare, benign tumor usually occurring in childhood. It is essentially localized in the extremities and trunk, with few cases reported in the neck. We report the case...
8.
Abdeljaoued S, Bettaieb L, Nasri M, Adouni O, Goucha A, Bouzaiene H, et al.
Breast Dis
. 2018 Mar;
37(3):109-114.
PMID: 29504520
Background: Male breast cancer (MBC) is a rare and neglected disease. Prognostic and predictive factors in MBC are extrapoled from trials conducted on its female counterpart. Objective: Since the relationship...
9.
Gabsi A, El Amine El Hadj O, Goucha A, Said G, Laabidi B, Gamoudi A
Tunis Med
. 2018 Feb;
95(2):97-102.
PMID: 29424867
Introduction: Medullary thyroid carcinoma is a rare tumor accounting for less than 10% of thyroid neoplasm. This tumor is characterized by important histological polymorphism which makes morphological diagnosis difficult and...
10.
Darouich S, El Amine El Hadj O, Betaieb I, Goucha A, Dhiab T, Rahal K, et al.
Tunis Med
. 2018 Jan;
95(1):37-44.
PMID: 29327767
Purpose: The aim of this study was to describe the clinico-epidemiological and histopronostic characteristics of triple negative breast cancer (TNBC) and to evaluate the therapeutic results in tunisian women. Methods:...